Last reviewed · How we verify

DWP16001 drug B

Daewoong Pharmaceutical Co. LTD. · Phase 1 active Small molecule

DWP16001 drug B is a Small molecule drug developed by Daewoong Pharmaceutical Co. LTD.. It is currently in Phase 1 development.

At a glance

Generic nameDWP16001 drug B
SponsorDaewoong Pharmaceutical Co. LTD.
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about DWP16001 drug B

What is DWP16001 drug B?

DWP16001 drug B is a Small molecule drug developed by Daewoong Pharmaceutical Co. LTD..

Who makes DWP16001 drug B?

DWP16001 drug B is developed by Daewoong Pharmaceutical Co. LTD. (see full Daewoong Pharmaceutical Co. LTD. pipeline at /company/daewoong-pharmaceutical-co-ltd).

What development phase is DWP16001 drug B in?

DWP16001 drug B is in Phase 1.

Related